Mont Pharmaceuticals Private Limited
About Mont Pharmaceuticals Private Limited
Data last updated:
Mont Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It was incorporated on 18 October 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U47721DL2024PTC437901.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Akshay Raj Saxena and Sunil Kumar Saxena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹64,828. For the same year it recorded a net loss of ₹1.1 Lakh (net margin -169.7%) and EBITDA of -₹1.08 Lakh (EBITDA margin -166.1%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressD – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Mont Pharmaceuticals Private Limited FY 2025 filings available
Mont Pharmaceuticals Private Limited reported revenue of ₹64,828 for FY 2025.
Financial Statement Summary of Mont Pharmaceuticals Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | •••• |
| Other Income | •••• |
| Total Revenue | •••• |
| Cost of Materials Consumed | •••• |
| Employee Benefit Expense | •••• |
| Finance Costs | •••• |
| Depreciation and Amortisation | •••• |
| Other Expenses | •••• |
| Total Expenses | •••• |
| EBITDA | -₹1.08 Lakh |
| Profit Before Tax | •••• |
| Tax Expense | •••• |
| Net Profit (PAT) | -₹1.1 Lakh |
| Balance Sheet | |
| Share Capital | •••• |
| Reserves and Surplus | •••• |
| Net Worth (Total Equity) | •••• |
| Long-term Borrowings | •••• |
| Short-term Borrowings | •••• |
| Trade Payables | •••• |
| Total Liabilities | •••• |
| Fixed Assets | •••• |
| Investments | •••• |
| Inventories | •••• |
| Trade Receivables | •••• |
| Cash and Bank Balance | •••• |
| Total Assets | •••• |
Financial Ratios of Mont Pharmaceuticals Private Limited
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -166.1% |
| Net Profit Margin | -169.7% |
| Return on Equity (ROE) | •••• |
| Return on Capital Employed (ROCE) | •••• |
| Return on Assets (ROA) | •••• |
| Liquidity and Debt | |
| Current Ratio | •••• |
| Quick Ratio | •••• |
| Debt-to-Equity Ratio | •••• |
| Interest Coverage Ratio | •••• |
| Efficiency and Growth | |
| Asset Turnover | •••• |
| Receivable Days | •••• |
| Payable Days | •••• |
| Inventory Days | •••• |
| Revenue Growth | •••• |
| Net Profit Growth | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Mont Pharmaceuticals are in the company report.
Financial statements from FY 2025
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akshay Raj Saxena | Director | 18 Oct 2024 | 2 Years 0 Months | Current |
| Sunil Kumar Saxena | Director | 18 Oct 2024 | 2 Years 0 Months | Current |
Peer Comparison of Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Truvida Pharmaceuticals Private Limited | ₹66,451 (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Prarthana Pharmaceuticals Private Limited | ₹66,013 (FY 2025) | •••• | •••• | -93.0% | •••• | Gaya, Bihar, India |
| Aarudhra Pharmaceuticals Private Limited | ₹66,000 (FY 2022) | •••• | •••• | •••• | Tirupur, Tamil Nadu, India | |
| Nervet Pharmaceuticals Private Limited | ₹65,820 (FY 2024) | •••• | •••• | •••• | Haridwar, Uttarakhand, India | |
| Mclaren Pharmaceuticals Private Limited | ₹65,568 (FY 2015) | •••• | •••• | •••• | Mandideep, Madhya Pradesh, India | |
| Mont Pharmaceuticals Private Limited this company | ₹64,828 (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Expergen Pharmaceuticals Private Limited | ₹63,630 (FY 2020) | •••• | •••• | 10.0% | •••• | Andheri East Mumbai, Maharashtra, India |
| Magisca Pharmaceuticals Private Limited | ₹63,622 (FY 2025) | •••• | •••• | -33.0% | •••• | New Delhi, Delhi, India |
| Pushkar Pharmaceuticals Pvt Ltd | ₹63,000 (FY 2024) | •••• | •••• | 23.0% | •••• | Chandigarh, India |
| Mankem Pharmaceuticals Private Limited | ₹62,976 (FY 2025) | •••• | •••• | -20.0% | •••• | Jehanabad, Bihar, India |
| Lasis Pharmaceuticals Private Limited | ₹62,451 (FY 2025) | •••• | •••• | 217.0% | •••• | Darbhanga, Bihar, India |
Peers are the five companies nearest above and the five nearest below Mont Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Mont Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Mont Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Akshay Raj Saxena was appointed as Director on 18 Oct 2024.
Credit Ratings, Litigation & Regulatory Alerts for Mont Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Mont Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Mont Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Mont Pharmaceuticals Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Mont Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mont Pharmaceuticals Private Limited
Mont Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. It was incorporated on 18 October 2024 (2+ years old) and is registered under CIN U47721DL2024PTC437901.
Mont Pharmaceuticals reported revenue of ₹64,828 for FY 2025.
Mont Pharmaceuticals has 2 current directors:
- Akshay Raj Saxena - Director
- Sunil Kumar Saxena - Director
Mont Pharmaceuticals reported a net loss of ₹1.1 Lakh (net margin -169.7%) and EBITDA of -₹1.08 Lakh (EBITDA margin -166.1%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Mont Pharmaceuticals is U47721DL2024PTC437901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mont Pharmaceuticals was incorporated on 18 October 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Mont Pharmaceuticals by revenue are Truvida Pharmaceuticals Private Limited, Prarthana Pharmaceuticals Private Limited, Aarudhra Pharmaceuticals Private Limited, Nervet Pharmaceuticals Private Limited, Mclaren Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Akshay Raj Saxena was appointed as Director on 18 Oct 2024. Sunil Kumar Saxena was appointed as Director on 18 Oct 2024.
The registered office of Mont Pharmaceuticals is at D – 49B, Block – D Shakarpur, New Delhi, Delhi, India – 110092.
Mont Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
No. Mont Pharmaceuticals is not listed on any stock exchange. It is an unlisted company.